Joint Webinar from Noble & Aptar Pharma Discusses How to Improve Patient Adherence and Compliance With Innovative Digital Healthcare Solutions Hear from Adam Shain, Business Development Director, Digital Healthcare, Aptar… Read More »
Startling statistics have revealed the magnitude of the global opioid epidemic. According to the World Health Organization (WHO), in 2018 about 58 million people worldwide used opioids, and another 35.6… Read More »
Part 1 of Noble’s Human Factors + Webinar Series: Regulatory Overview Join Noble’s Joe Reynolds and Joe Masci, along with Human Factors expert Kevin Cluff, in the first of our… Read More »
According to the US FDA, human factors engineering is an essential component of product development for drug delivery and medical devices. The US FDA recommends making it a robust part… Read More »
“Human Factors Plus” (HF+) is a natural extension of Noble’s deep understanding of the patient experience when it comes to self-administering drug therapies ORLANDO, Fla. (February 2, 2021) – Noble,… Read More »
The biopharmaceutical industry has experienced incredible exponential growth in recent decades. Annual revenues have increased from US$4.4 billion (ÂŁ3.4 billion) in 1990 to $275 billion (ÂŁ213 billion) in 2018 (a… Read More »